Business

RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13

Jul 12, 2025 - 22:00
 0
RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13
Read More

Related Posts

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

Mar 21, 2025  0

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025  4

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

ZipRecruiter SVP Bartolome Lora sells $12,861 in shares

Mar 21, 2025  1

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025  0

ZipRecruiter president David Travers sells $106,161 in stock

ZipRecruiter president David Travers sells $106,161 in ...

Mar 21, 2025  0

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025  0